First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect
5 (138) In stock
![](https://ars.els-cdn.com/content/image/1-s2.0-S2589537021000778-gr1.jpg)
![](https://ars.els-cdn.com/content/image/1-s2.0-S2211383522000752-gr1.jpg)
Suppressing fatty acid synthase by type I interferon and chemical
![](https://www.natap.org/2021/images/112021/112021-2/1120218.gif)
Novel, first-in-class, fatty acid synthase inhibitor, TVB-2640
![](https://minio.scielo.br/documentstore/1678-2690/3K38r6DKNXG8VNhvnSrHxMQ/749f0d9903663b3b90b7c4fe089784f84add1c56.jpg)
SciELO - Brasil - Fatty acid synthase as a potential new
![](https://www.caymanchem.com/images/catalog/screen/35703.png)
TVB-2640 (Denifanstat, Fatty Acid Synthase Inhibitor 2, FASN-IN-2
![](https://ars.els-cdn.com/content/image/1-s2.0-S2211383522000752-figs1.jpg)
Suppressing fatty acid synthase by type I interferon and chemical
![](https://ars.els-cdn.com/content/image/3-s2.0-B9780323905282000102-f02-02-9780323905282.jpg)
Fatty Acid Synthase Inhibitor - an overview
![](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223015391-ga1.jpg)
Acetyl-CoA metabolism as a therapeutic target for cancer
![](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223015391-gr6.jpg)
Acetyl-CoA metabolism as a therapeutic target for cancer
![](https://www.researchgate.net/profile/Jing-Xiong-15/publication/354886240/figure/tbl1/AS:1098754333655041@1638974855165/continued_Q320.jpg)
PDF) Metabolic dysregulation and emerging therapeutical targets
![](https://ars.els-cdn.com/content/image/1-s2.0-S0928098722001427-ga1.jpg)
Randomized, double-blinded, placebo-controlled phase I study of
fajas con ciper - Buy fajas con ciper with free shipping on AliExpress
BYBEST Fajas Reductoras Mujer Abdomen Fajas Moldeadoras de Cintura para Mujer
Bybest Fajas Reductoras Mujer Fajas de Levantamiento de glúteos para Mujer pantalón Corto Moldeador